首页> 外国专利> Process for preparing new derivatives Race- monkeys and optically active 9- and 11-aminoeburnano-carboxylic

Process for preparing new derivatives Race- monkeys and optically active 9- and 11-aminoeburnano-carboxylic

机译:制备新衍生物竞速猴和旋光的9-和11-氨基氨基丁烷羧酸的方法

摘要

(A) 9- or 11-Amino-eburnane-carboxylic acid derivs. of formula (I) and their optical isomers and salts are new. R = NH2, NHCOR1 or NHSO2R2 in the 9 or 11 posn.; R1 = H or opt. substd. 1-10C aliphatic hydrocarbyl, 3-8C cycloaliphatic hydrocarbyl, 6-14C aryl or heteroaryl; R2 = opt. substd. 1-10C aliphatic hydrocarbyl or 6-14C aryl; R3 = H or opt. substd. 1-10C aliphatic hydrocarbyl, 3-8C cycloaliphatic hydrocarbyl or 6-14C aryl; A = OH; B = H; or A+B = direct bond; provided that R3 is not Me when (a) R = NH2 or (b) R = 11-acetamido, A = OH and B = H. (B) Prodn. of eburnane-carboxylic acid derivs., 11-acetamido-vincamine or 9- or 11-amino-apovincamine is effected by: (a) acylating a cpd. (I) where R3 = Me or where R3 = H and A+B = bond, opt. after hydrolysis, excluding acetylation when R4 = Me, A = OH and B = H, opt. followed by (i) esterificn. or transesterificn. of prods. where R = NHCOR1 or NHSO2R2, (ii) hydrolysis of prods. where R = NHCOR1 or NHSO2R2, A = OH, B = H and R3 is other than H, and/or (iii) dehydration of prods. where A = OH and B = H; (b) esterifying or transesterifying a cpd. (I) where R3 = Me or R3 = H and A+B bond, opt. followed by (i) hydrolysis of prods. where R = NH2, A = OH, B = H and R3 is other than H, (ii) dehydration of prods. where A = OH and B = H, and/or (iii) acylation of prods. where R = NH2 and R3 is as defined in (A) or is Me; or (c) reducing cpds. of formula (I) where R = NO2, opt. followed by reactions as defined in (a)(i) and/or (a)(ii) or in (b)(i) and/or (a)(iii) or in (b)(ii) and/or (b)(iii). (C) Medicaments contg. cpds. (I) as defined in (A) and/or 11-acetamido-vincamine are new.
机译:(A)9-或11-氨基-庚烷-羧酸衍生物。式(I)的化合物及其光学异构体和盐是新的。在9或11位上,R = NH 2,NHCOR 1或NHSO 2 R 2。 R1 = H或opt。取代1-10C脂族烃基,3-8C脂环族烃基,6-14C芳基或杂芳基; R2 =优化取代1-10C脂族烃基或6-14C芳基; R3 = H或opt。取代1-10C脂族烃基,3-8C脂环族烃基或6-14C芳基; A = OH; B = H;或A + B =直接键;前提是当(a)R = NH2或(b)R = 11-乙酰氨基,A = OH和B = H时R3不是Me。氨基甲酸酯-羧酸衍生物,11-乙酰氨基-长曲胺或9-或11-氨基-apovincamine的制备可通过以下方法实现:(a)酰化cpd。 (I)其中R3 = Me或R3 = H且A + B =键。水解后,不包括乙酰化(当R4 = Me,A = OH和B = H时)。其次是(i)酯化。或酯交换。的产品。其中R = NHCOR1或NHSO2R2,(ii)产物的水解。其中R = NHCOR1或NHSO2R2,A = OH,B = H且R3不是H,和/或(iii)产物脱水。其中A = OH,B = H; (b)将cpd酯化或酯交换。 (I)其中R3 = Me或R3 = H和A + B键,选择。然后(i)水解产物。其中R = NH 2,A = OH,B = H并且R 3不是H,(ii)产物的脱水。其中A = OH,B = H,和/或(iii)产物的酰化。其中R = NH 2且R 3如(A)中所定义或为Me;或(c)减少cpds。式(I)的通式,其中R = NO 2,最佳。随后进行(a)(i)和/或(a)(ii)或(b)(i)和/或(a)(iii)或(b)(ii)和/或( b)(iii)。 (C)药品续cpds。 (A)中定义的(I)和/或11-乙酰氨基-长春胺是新的。

著录项

  • 公开/公告号ES545116A0

    专利类型

  • 公开/公告日1986-01-01

    原文格式PDF

  • 申请/专利权人 RICHTER GEDEON VEGYESZETI GYAR R.T.;

    申请/专利号ES19850545116

  • 发明设计人

    申请日1985-07-11

  • 分类号C07D471/22;C07D209/14;C07D207/16;A61K31/445;

  • 国家 ES

  • 入库时间 2022-08-22 07:37:51

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号